← Back to Search

Calcium Supplement

Bisphosphonates/Non-Micronized Calcium Carbonate/Vitamin D3 for Osteoporosis

N/A
Waitlist Available
Led By Gilbert R Kaats, PhD FACN
Research Sponsored by Integrative Health Technologies, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 183 days
Awards & highlights
No Placebo-Only Group

Summary

The purpose of this study is to determine whether consuming calcium carbonate that has been micronized is more effective than the traditional form of calcium carbonate in maintaining or increasing bone mineral density in people who are currently taking bisphosphonates or other bone-health medications.

Eligible Conditions
  • Osteoporosis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0 and 183 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 0 and 183 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Absorptiometry, X-Ray
Secondary study objectives
Blood Chemistry Panel
Number of participants with adverse effects
Resting heart rate
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

4Treatment groups
Active Control
Group I: Bisphosphonates/Non-Micronized Calcium Carbonate/Vitamin D3Active Control2 Interventions
Subjects currently being treated with Bisphosphonates will replace any calcium they are currently taking with four Capsules/Day containing a total amount of 1000 mg of Non-Micronized Calcium Carbonate and 800 IU Vitamin D3.
Group II: Micronized Calcium Carbonate/Vitamin D3Active Control2 Interventions
Subjects who are not currently being treated with Bisphosphonates will replace any calcium they are currently taking with four Capsules/Day containing a total of 500 mg of Micronized Calcium Carbonate and 800 IU Vitamin D3
Group III: Non-Micronized Calcium Carbonate/Vitamin D3Active Control2 Interventions
Subjects who are not currently being treated with Bisphosphonates will replace any calcium they are currently taking with four Capsules/Day containing a total of 1000 mg of Non-Micronized Calcium Carbonate and 800 IU Vitamin D3.
Group IV: Bisphosphonates/Micronized Calcium Carbonate/Vitamin D3Active Control2 Interventions
Subjects currently being treated with Bisphosphonates will replace any calcium they are currently taking with four Capsules/Day containing a total amount of 500 mg of Micronized Calcium Carbonate and 800 IU Vitamin D3

Find a Location

Who is running the clinical trial?

Integrative Health Technologies, Inc.Lead Sponsor
5 Previous Clinical Trials
849 Total Patients Enrolled
Gilbert R Kaats, PhD FACNPrincipal InvestigatorIntegrative Health Technologies, Inc.
3 Previous Clinical Trials
425 Total Patients Enrolled
Sidney J Stohs, PhDStudy DirectorDean Emeritus, Creighton University Health Sciences Center
2 Previous Clinical Trials
225 Total Patients Enrolled
~13 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top